Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00370916 · ClinicalTrials.gov registry record · NA
Reducing Transition Drug Risk
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 612
- Enrollment target
NCT00370916 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 612 participants.
The verdict
NCT00370916, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 612 participants
- Enrollment target
Study Summary
Patient transfer between sites of care is regular practice during an episode of care in our current health care system. Yet inter-site transfer is associated with lapses in care quality that adversely affect patient outcomes. A common iatrogenic harm precipitated at the time of transfer is harm from drug prescribing, or adverse drug events (ADEs). In this study we will evaluate a medication reconciliation tool developed to help providers make effective prescribing decisions at the time of transfer between VA sites of care (Improved Prescribing after Transfer (IPT)). We will evaluate the quantitative effectiveness of the tool in reducing transition drug risk and ADEs. We additionally will conduct focus group discussions and cognitive task analysis among end-users to better understand how providers make drug-prescribing decisions at the time of transfer and to assess factors influencing effective use of the tool.
Interventions
- BEHAVIORAL Physician-initiated medication reconciliation
- BEHAVIORAL Pharmacist-initiated medication reconciliation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 612 participants |
| Start Date | 2005-10 |
| Est. Completion | 2010-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00370916
The ClinicalTrials.gov registry entry for NCT00370916 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 612 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Physician-initiated medication reconciliation is the first listed.
NCT00370916 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00370916 about?
NCT00370916 is a clinical study titled "Reducing Transition Drug Risk". Patient transfer between sites of care is regular practice during an episode of care in our current health care system. Yet inter-site transfer is associated with lapses in care quality that adversely affect patient outcomes. A common iatrogenic harm precipitated at the time of transfer is harm from...
What is the current status of trial NCT00370916?
This trial is currently completed. It is a NA study. The enrollment target is 612 participants. The study started on 2005-10. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00370916?
The interventions under investigation include: Physician-initiated medication reconciliation (BEHAVIORAL), Pharmacist-initiated medication reconciliation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00370916?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.